CORCEPT THERAPEUTICS INC Property, Plant and Equipment, Gross
CORCEPT THERAPEUTICS INC (CORT) had Property, Plant and Equipment, Gross of $4.48 million as of 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2023-08-02
- 2023-06-30: Property, Plant and Equipment, Gross $4.48M.
- 2023-03-31: Property, Plant and Equipment, Gross $4.34M.
- 2022-12-31: Property, Plant and Equipment, Gross $4.34M.
- 2022-09-30: Property, Plant and Equipment, Gross $4.33M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2023-06-30 | $4.48M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $4.34M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $4.34M 10-Q · filed 2023-08-02 |
| 2022-09-30 | $4.33M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.19M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.94M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.93M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $3.86M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $3.78M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $3.59M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.53M 10-Q · filed 2021-11-03 |
| 2018-12-31 | $1.28M 10-K · filed 2020-02-24 |
| 2017-12-31 | $907.00K 10-K · filed 2019-02-26 |
| 2016-12-31 | $657.00K 10-K · filed 2018-02-28 |
| 2015-12-31 | $463.00K 10-K · filed 2017-03-06 |
| 2014-12-31 | $525.00K 10-K · filed 2016-03-10 |
| 2013-12-31 | $351.00K 10-K · filed 2015-03-13 |
| 2012-12-31 | $227.00K 10-K · filed 2014-03-14 |
| 2011-12-31 | $76.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |